Pathophysiology and Management of Mild to Moderate Pediatric Atopic Dermatitis Journal Supplement
Important: This continuing education activity is FREE to NAPNAP Members. You must be logged in to use your NAPNAP Member ID# and Password to be recognized as a Member of NAPNAP. If you are a current member of NAPNAP, and you are being asked to purchase this activity, please contact the NAPNAP National Office at (877) 662-7627 to request assistance prior to entering any information.
This continuing education activity is administered by the National Association of Pediatric Nurse Practitioners (NAPNAP) as an Agency providing continuing education credit. Individuals who complete this program and earn a 70% or higher score on the post test will be awarded 1.0 NAPNAP contact hours of which 0.5 is pharmacology content.
This educational activity is sponsored by Spire Learning, and accredited by the National Association of Pediatric Nurse Practitioners.
This activity is supported by an educational grant from Pfizer Inc.
LEVELS OF EVIDENCE
Two types of grades are provided for any treatment recommendations made in this activity.
|Level of Evidence||Strength of Clinical Recommendation|
- Used to evaluate available evidence based on the quality of study methodology and the overall focus of the study
I. Good-quality patient-oriented evidence (ie, evidence measuring outcomes that matter to patients: morbidity, mortality, symptom improvement, cost reduction, and quality of life)
- Developed based on the best available evidence
A. Recommendation based on consistent and good-quality patient-oriented evidence
Source: American Academy of Dermatology Guidelines of Care for the Management of Atopic Dermatitis
Pediatric-focused advanced practice registered nurses (APRNs)
- Summarize the role of skin barrier dysfunction and inflammatory pathways and responses in AD pathogenesis
- Identify management strategies for mild to moderate AD based on patient and caregiver preferences, adherence, and concerns
- Describe the efficacy and safety of currently available therapies and their potential role in the management of mild to moderate AD
- Implement into practice shared decision-making strategies to increase patient and caregiver involvement in AD management
The opinions expressed in this educational activity are those of the faculty and do not represent those of NAPNAP or Spire Learning. This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically and draw conclusions only after careful consideration of all available scientific information.
This educational activity may contain discussion of published and/or investigational uses of therapies that were not indicated by the FDA at the time of publication, including roflumilast and apremilast. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, participants are encouraged to consult appropriate resources for any product or device mentioned in this activity.
CONFLICT OF INTEREST STATEMENTS
According to the disclosure policy of NAPNAP, all faculty, planning committee members, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interests related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity, and levels of evidence. Disclosures are as follows:
Please refer to the Faculty Presenters section for each faculty member’s affiliation and disclosure statement.
Kammi Yap Sayaseng, DNP, RN, PNP-BC, IBCLC
Assistant Professor, Graduate Program Coordinator
California State University, Fresno, School of Nursing
Kammi Yap Sayaseng, DNP, RN, PNP-BC, IBCLC, is an Assistant Professor and Graduate Program Coordinator in the School of Nursing at California State University in Fresno. In addition to teaching full time, she works part time as a primary provider Pediatric Nurse Practitioner in an outpatient setting. Dr Sayaseng received her undergraduate and master’s degrees in nursing from California State University in Fresno. She received her Doctor of Nursing Practice from the University of San Francisco, in California.
Dr Sayaseng’s primary clinical focus is the treatment and management of pediatric skin conditions, including atopic dermatitis. She is a frequent presenter of dermatology topics at local and national meetings and has authored continuing education activities for the National Association of Pediatric Nurse Practitioners (NAPNAP). An active NAPNAP member, Dr Sayaseng is president of the San Joaquin Valley Chapter and a Nominations Committee member of the national NAPNAP.
No relevant financial relationships with any commercial interests.
Peggy Vernon, RN, MA, CPNP, DCNP, FAANP
Dermatology Nurse Practitioner
Owner, Creekside Skin Care
Peggy Vernon, RN, MA, CPNP, DCNP, is a Dermatology Nurse Practitioner and owner of Creekside Skin Care, a full-service dermatology practice in Centennial, Colorado. Ms Vernon earned her pediatric nurse practitioner certificate from the University of Colorado Health Sciences Center, in Denver. She received her master’s degree in agency counseling from the University of Northern Colorado, in Greeley, and her post-master’s nurse practitioner certificate in dermatology from Regis University in Denver, Colorado.
Ms Vernon’s clinical interests include all clinical dermatology, especially pediatric dermatology. She is a frequent speaker at national and international meetings and to her credit has more than a dozen publications, including peer-reviewed journals and book chapters. During her distinguished career, Ms Vernon has received many honors and awards. She has the distinction of being Colorado’s first dermatology nurse practitioner, and most recently, Ms Vernon was named as a Fellow of the American Association of Nurse Practitioners.
No relevant financial relationships with any commercial interests.
Educational Planning Committee
National Association of Pediatric Nurse Practitioners
Heather Keesing, MSN, RN, APRN; Laura Nelsen; Alexandra Rojas: No relevant financial relationships with any commercial interests.
Aisha Cobbs, PhD, and Molly Vrana: No relevant financial relationships with any commercial interests.
Heather Keesing, MSN, RN, APRN: No relevant financial relationships with any commercial interests.
This program is accredited for 1.0 NAPNAP CE contact hour of which 0.5 contain pharmacology (Rx) content, per the National Association of Pediatric Nurse Practitioners Continuing Education Guidelines.
- 1.00 Contact hours